Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Prostate Cancer and Prostatic Diseases|January 28, 2021
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched studyTaimur T Shah, Deepika Reddy, Max Peters, et al.
Scientific Reports|October 15, 2020
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologistsLina Maria Carmona Echeverria, Aiman Haider, Alex Freeman, et al.
European Urology|April 22, 2020
Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS StudyAhmed El-Shater Bosaily, Elena Frangou, Hashim U Ahmed, et al.
JAMA Oncology|February 12, 2026
Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate CancerAlexander Light, Max Peters, Manit Arya, et al.
BMJ Open|February 26, 2021
Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trialMartin John Connor, Taimur Tariq Shah, Katarzyna Smigielska, et al.
Plos Genetics|September 26, 2017
Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence dataNiedzica Camacho, Peter Van Loo, Sandra Edwards, et al.
Nature Genetics|March 3, 2015
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissueColin S Cooper, Rosalind Eeles, David C Wedge, et al.
Nature Genetics|April 18, 2018
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targetsDavid C Wedge, Gunes Gundem, Thomas Mitchell, et al.
The Lancet. Oncology|October 22, 2021
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective studyElizabeth K Bancroft, Elizabeth C Page, Mark N Brook, et al.
European Urology|February 19, 2026
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT StudyElizabeth K Bancroft, Elizabeth C Page, Jana McHugh, et al.
Pageof 6